Shalom Life | May 08, 2014

WWII Survivor, Alzheimer's Researcher Wins Israel Prize for Medicine

Professor Emeritus Marta Weinstock-Rosin, who developed what is now one of the most commonly-used treatments for Alzheimer’s and Parkinson’s, Rivastigmine, is being honoured for her work in the field of medicine

By: NoCamels Team

Published: March 5th, 2014 in Health » Israel

This story is everything we love: Breakthrough Israeli medical research that benefits millions around the world; an audacious female scientist; and a well-deserved prize at the end.

The daring whizz we are referring to is Professor Emeritus Marta Weinstock-Rosin, a WWII survivor who in the 1990's developed what is now one of the most commonly-used treatments for Alzheimer’s and Parkinson’s, Rivastigmine. Now her achievements just crowned her this year’s Israel Prize winner for Medicine, largely regarded as the state’s highest honor.

The Israel Prize is traditionally given in a ceremony that takes place on Israeli Independence Day, and is attended by the prime minister, the president, the Knesset speaker and the Supreme Court president.

Weinstock-Rosin was the lead developer for what would eventually become the Novartis Exelon Patch, the only FDA-approved skin patch for the treatment of Alzheimer’s disease.

Rivastigmine, the generic name for Exelon, prevents the breakdown of acetylcholine by an enzyme called acetylcholinesterase. The more acetylcholinesterase, the better nerve cells can communicate with each other, Weinstock-Rosin’s research showed, so by preventing the breakdown of acetylcholine, the progress of Alzheimer’s can be stopped, or even halted.

Novatis, which acquired Exelon from the Hebrew University’s technology transfer company, Yissum, generated more than $1 billion in sales of Exelon in 2012. As there currently is no cure for Alzheimer’s, Exelon is considered one of the more effective treatments for the disease.

From escaping the Nazis to battling Alzheimer’s

Weinstock-Rosin is married with four children and 20 grandchildren. She was born in Vienna in 1935 and at the age of four escaped the Nazis with her family to England, where she stayed for 30 years. She studied Pharmacology at the University of London, where she obtained her BPharm and an MSc. She received her PhD at St. Mary’s Hospital Medical School and later went back to the University of London to become a lecturer in pharmacology.

In 1969, she moved to Israel with her husband and children and joined Tel Aviv University’s medical faculty. From 1976-77 she took a research sabbatical at the US National Institutes of Health and received a grant from the NIH’s National Institute on Drug Abuse for her research on the mechanism of action of opiates.

She became a professor at the Hebrew University in 1981 and head of its School of Pharmacy in 1983. Her current research is focused on drugs that improve brain function and memory in patients with degenerative diseases of the central nervous system.

Weinstock-Rosin is also the co-developer, with Professor Moussa Youdim of the Technion Israel Institute of Technology, of Ladostigil. During its development Weinstock-Rosin discovered that at low doses Ladostigil prevents brain degeneration and memory impairment in aged rats. The drug is now undergoing Phase II clinical trials in Israel and Europe for the prevention of Alzheimer’s disease.

Reprinted with permission from No Camels - Israeli Innovation News

One Kenton: A Unique Communal Residence for Alzheimer's Patients One Kenton: A Unique Communal Residence for Alzheimer's Patients Trending Gleasons Gym Teaching Krav Maga Trending Study: Bilingual Children Are Smarter Trending
 

Breakthrough Jew - Neil Blumenthal

May 08, 2014 | By Sarah Bauder

Blumenthal is the co-founder of popular eyewear retailer, Warby Parker.

Read More

Amar’e Stoudemire is More Jewish Than You Thought [VIDEO]

May 08, 2014 | By Ashley Baylen

TMZ caught up with the basketball player's wife to discuss Bar Mitzvahs, Shabbat, Passover, and more

Read More

Sarah Silverman’s Brother-in-Law Joins Israeli Presidential Race

May 08, 2014 | By Ashley Baylen

Solar power entrepreneur Yosef Abramowitz is running in the upcoming election.

Read More

Scarlett Johansson, Mila Kunis and Dianna Agron Land on ‘Sexiest Women in The World’ List

May 08, 2014 | By Ashley Baylen
Scarlett Johansson, Mila Kunis and Dianna Agron Land on ‘Sexiest Women in The World’ List

10 Jewish celebrities made this year's list released by FHM magazine

Read More

Startup Club: Grouper

May 08, 2014 | By Caitlin Marceau

Done with dating? A new social media app makes meeting people even easier than Tinder or JDate

Read More

Rami Fortis to Open for Rolling Stones in Tel Aviv

May 08, 2014 | By Emma Mazerall

The legendary Israeli rocker will perform before the iconic rock n roll band takes the stage on June 4th

Read More

UPS Deliveryman Also A Matchmaker

May 08, 2014 | By Daniel Koren

Terry Spiers introduced Zev Goldin and Chana Simon to one another, who lived blocks away from each other in Crown Heights

Read More

Ukrainian Jews Create Task Force to Fight Against anti-Semitism

May 08, 2014 | By Daniel Koren
Ukrainian Jews Create Task Force to Fight Against anti-Semitism

An eight-man unit has been set up in Kiev, with members having experience in either the IDF or with martial arts

Read More

More Headlines